IN VIVO MODEL EVALUATION FOR PRECLINICAL DRUG DEVELOPMENT

In vivo assays are essential tools in preclinical drug development, enabling researchers to determine the efficacy and safety of novel drugs in a living organism. Choosing the appropriate model is crucial to confirm relevant preclinical results. This involves a comprehensive understanding of the disease being studied, as well as the drawbacks of ea